A 4550New Jersey

Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

In committee

Mar 10, 2026: Introduced, Referred to Assembly Financial Institutions and Insurance Committee

Follow this bill Ratifi